Evidence map›Paper›PMID 32784857›Full record

ArticleGenes2020

Retrospective Analysis Shows That Most RHDV GI.1 Strains Circulating Since the Late 1990s in France and Sweden Were Recombinant GI.3P-GI.1d Strains.

Joana Abrantes, Ana M Lopes, Evelyne Lemaitre, Harri Ahola, Fereshteh Banihashem, Clément Droillard, Stéphane Marchandeau, Pedro J Esteves, Aleksija Neimanis, Ghislaine Le Gall-Reculé

Abstract readHistorical Article
In one paragraph

Article in Genes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Characterisation ofInternational journal of molecular sciences · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Joana AbrantesCIBIO/InBio-UP, Centro de Investigação em Biodiversidade e Recursos Genéticos, Universidade do Porto, 4485-661 Vairão, Portugal.
Ana M LopesCIBIO/InBio-UP, Centro de Investigação em Biodiversidade e Recursos Genéticos, Universidade do Porto, 4485-661 Vairão, Portugal.ORCID 0000-0002-7176-0969
Evelyne LemaitreUnité de Virologie, Immunologie, Parasitologie, Aviaires et Cunicoles, Laboratoire de Ploufragan-Plouzané-Niort, Agence nationale de sécurité sanitaire, de l'alimentation, de l'environnement et du travail (Anses), 22440 Ploufragan, France.
Harri AholaDepartment of Microbiology, National Veterinary Institute (SVA), Ulls väg 2B, SE75189 Uppsala, Sweden.
Fereshteh BanihashemDepartment of Microbiology, National Veterinary Institute (SVA), Ulls väg 2B, SE75189 Uppsala, Sweden.
Clément DroillardUnité de Virologie, Immunologie, Parasitologie, Aviaires et Cunicoles, Laboratoire de Ploufragan-Plouzané-Niort, Agence nationale de sécurité sanitaire, de l'alimentation, de l'environnement et du travail (Anses), 22440 Ploufragan, France.ORCID 0000-0002-3106-6649
Stéphane MarchandeauUnité Petite Faune Sédentaire et Espèces Outre-Mer, Direction de la Recherche et de l'Appui Scientifique, Office Français de la Biodiversité (OFB), 44300 Nantes, France.
Pedro J EstevesCIBIO/InBio-UP, Centro de Investigação em Biodiversidade e Recursos Genéticos, Universidade do Porto, 4485-661 Vairão, Portugal.
Aleksija NeimanisDepartment of Pathology and Wildlife Diseases, National Veterinary Institute (SVA), Ulls väg 2B, SE75189 Uppsala, Sweden.ORCID 0000-0001-7747-2290
Ghislaine Le Gall-ReculéUnité de Virologie, Immunologie, Parasitologie, Aviaires et Cunicoles, Laboratoire de Ploufragan-Plouzané-Niort, Agence nationale de sécurité sanitaire, de l'alimentation, de l'environnement et du travail (Anses), 22440 Ploufragan, France.ORCID 0000-0003-4557-6532

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recombination is one of the major sources of genetic variation in viruses. RNA viruses, such as rabbit hemorrhagic disease virus (RHDV), are among the viruses with the highest recombination rates. Several recombination events have been described for RHDV, mostly as a consequence of their genomic architecture. Here, we undertook phylogenetic and recombination analyses of French and Swedish RHDV strains from 1994 to 2016 and uncovered a new intergenotypic recombination event. This event occurred in the late 1990s/early 2000s and involved nonpathogenic GI.3 strains as donors for the nonstructural part of the genome of these recombinants, while pathogenic GI.1d strains contributed to the structural part. These GI.3P-GI.1d recombinant strains did not entirely replace GI.1d (nonrecombinant) strains, but became the dominant strains in France and Sweden, likely due to a fitness advantage associated with this genomic architecture. GI.3P-GI.1d (P stands for polymerase) strains persisted until 2013 and 2016 in Sweden and France, respectively, and cocirculated with the new genotype GI.2 in France. Since strains from the first GI.2 outbreaks were GI.3P-GI.2, we hypothesize that GI.3P-GI.1d could be the parental strain. Our results confirm the outstanding recombination ability of RHDV and its importance in the evolution of lagoviruses, which was only revealed by studying complete genomic sequences.

Indexed as

Recombination, GeneticAnimal DiseasesAnimalsAnimals, WildCaliciviridae InfectionsEvolution, MolecularFranceGenome, ViralGenotypeHemorrhagic Disease Virus, RabbitHistory, 20th CenturyPhylogenyRetrospective StudiesRNA, ViralSwedenRNA, ViralGI.1dGI.3recombinationRHDV

Identifiers

PMID32784857
PMCPMC7464634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.